This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Different strategies of treatment for uterine cervical carcinoma stage IB2-IIB
Lucas Minig, María Guadalupe Patrono, Nuria Romero, Juan Francisco Rodríguez Moreno, Jesús Garcia-Donas
Lucas Minig, María Guadalupe Patrono, Gynecologic Oncology Program, Clara Campal Comprehensive Cancer Center, HM Hospitales, 28050 Madrid, Spain
Nuria Romero, Juan Francisco Rodríguez Moreno, Jesús Garcia-Donas, Gynecologic Oncology Program, Medical Oncology Department, Clara Campal Comprehensive Cancer Center, HM Hospitales, 28050 Madrid, Spain
Author contributions: Minig L, Patrono MG and Romero N performed the literature review and wrote the manuscript; Minig L, Rodríguez Moreno JF and Garcia-Donas J revised the manuscript.
Correspondence to: Lucas Minig, MD, PhD, Gynecology Oncology Program, Clara Campal Comprehensive Cancer Center, HM Hospitales, Calle Oña 10, 28050 Madrid, Spain. email@example.com
Telephone: +34-61-6952439 Fax: +34-91-2110119
Received: December 24, 2013 Revised: January 22, 2014 Accepted: April 16, 2014 Published online: May 10, 2014
Core tip: There is no currenty demonstrated the best option of treatment for women with locally advanced cervical cancer Federation of Gynecology and Obstetrics stage IB2-IIB. This article describe the evidence as well as the advantages and disadvantages of the main strategies of treatment.